Antitumour effects on human colorectal carcinomas cells by stable silencing of phospholipase C-gamma 1 with lentivirus-delivered siRNA

Chinese Medical Journal

Volumn 120, Issue 9, 2007, Pages 749-754

  Tan, Li ^a   Xiao, Bing Xiang ^a   Zeng, Wei Sen ^a   Lin, Jun ^a   Zou, Zhi Peng ^a   Xu, Ai Min ^b   Luo, Shen Qiu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adhesion; Apoptosis; Lentivirus; Migration; Phospholipase C gamma; siRNA

Indexed keywords

FLUOROURACIL; LENTIVIRUS VECTOR; MESSENGER RNA; PHOSPHOLIPASE C GAMMA; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 34248660287     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200705010-00003     Document Type: Article

References (30)

1. Fry DW, Ambroso LA. Expression of a 118 Kd protein in colon carcinoma cells that is immunologically related to PLC-gamma 1 and is augmented by serum-free conditions. Cancer Biochem Biophys 1993; 4: 265-278.
2. Noh DY, Lee YH, Kim SS, Kim YI, Ryu SH, Suh PG, et al. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 1994; 1: 36-41.
3. Lee SJ, Lee SD, Park JG, Kim CM, Ryu SH, Suh PG. Overexpression of phospholipase C-γ1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter. J Biol Chem 1995; 27: 16378-16384.
4. Nomoto Y, Tomita N, Miyake M, Xhu DB, LoGerfo PR, Weinstein IB. Expression of phospholipasesgamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol Carcinog 1995; 3: 146-152.
5. Mankidy R, Hastings J, Thackeray JR. Phospholipase C-γ-dependent signaling pathways in the Drosophila eye and wing are revealed by a new small wing allele. Genetics 2003; 2: 553-563.
6. Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech 1998; 43: 395-411.
7. Chen P, Xie H, Sekar MC, Gupta K, Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but MAP kinase activity is not sufficient for induced cell movement. J Cell Biol 1994; 127: 847-857.
8. Kundra V, Escobedo JA, Kazlauskas A, Kim UK, Rhee SG, Williams LT, et al. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 1994; 6462: 474-476.
9. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R. Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994; 93: 1266-1274.
10. Li X, Hua L, Deng F, Bai X, Zeng W, Lu D, et al. NF-kappaB and Hsp70 are involved in the phospholipase Cgamma 1 signaling pathway in colorectal cancer cells. Life Sci 2005; 22: 2794-2803.
11. Katterle Y, Brandt BH, Dowdy SF, Niggemann B, Zanker KS, Dittmar T. Antitumour effects of PLC-g1-(SH2)2-TAT fusion proteins on EGFR/ c-erbB-2-positive breast cancer cells. Br J Cancer 2004; 90: 230-235.
12. Kusumawati A, Commes T, Liautard JP, Widada JS. Transfection of myelomonocytic cell lines: cellular response to a lipid-based reagent and electroporation. Anal Biochem 1999; 1: 219-221.
13. Lieber A, Steinwaerder DS, Carlson CA, Kay MA. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J Virol 1999; 73: 9314-9324.
14. Qing K, Li W, Zhong L, Tan MQ, Hansen J, Kirsten A, et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular t-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgene mice in vivo. J Virol 2003; 4: 2741-2746.
15. Devroe E, Silver PA. Retrovirus-delivered siRNA. BMC Biotechnol 2002; 2: 15.
16. Sumimoto H, Miyagishi M, Miyoshi H, Yamagata S, Shimizu A, Taira K, et al. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene 2004; 23: 6031-6039.
17. Lee IH, You JO, Ha KS, Bae DS, Suh PG, Rhee SG, et al. AHNAK-mediated activation of phospholipase Cγ1 through Protein Kinase C. the J Biol Chem 2004; 25: 26645-26653.
18. Jimmy S. Lee, Hmama Z, Mui A, Reiner NE. Stable Gene Silencing in human monocytic cell lines using lentiviral-4elivered small interference RNA. J Biol Chem 2004; 10: 9379-9388.
19. Chen P, Gupta K, Wells A. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell 1994; 4: 547-555.
20. Hmama Z, Knutson KL, Herrera-Velit P, Nandan D, Reiner NE. Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinase. J Biol Chem 1999; 2: 1050-1057.
21. Fukami K, Endo T, Imamura M, Takenawa T. alpha-Actinin and vinculin are PIP2-binding proteins involved in signaling by tyrosine kinase. J Biol Chem 1994; 269: 1518-1522.
22. Gilmore AP, Burridge K. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 1996; 381: 531-535.
23. Burke B, Summer S, Maitland N, Lewis CE. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol 2002; 72: 417-428.
24. Hannon GJ. RNA interference. Nature 2002; 418: 244-251.
25. Follenzi A, Gupta S. The promise of lentiviral gene therapy for liver cancer. J Hepatol 2004; 40: 337-340.
26. Xie H, Pallero MA, Gupta K, Chang P, Ware MF, Witke W, et al. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLC-gamma signaling pathway. J Cell Sci 1998; 111:615-624.
27. Wells A, Grandis JR. Phospholipase C-gamma 1 in tumor progression. Clin Exp Metastasis 2003; 20:285-290.
28. Chen P, Murphy-Ullrich JE, Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol 1996; 134: 689-698.
29. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Different 2004; 11:915-923.
30. Bae SS, Perry DK, Oh YS, Choi JH, Galadari SH, Ghayur T, et al. Proteolytic cleavage of phospholipase C-gamma 1 during apoptosis in Molt-4 cells. FASEB J 2000; 9: 1083-1092.